Topic: Health
Researchers at Yale School of Medicine discovered how a misfolded protein called α-synuclein enters healthy brain cells. This could lead to new treatments that slow or stop Parkinson's disease progression.
Parkinson's disease is a serious neurological disorder that affects millions of people worldwide, including about 1.1 million Americans. It causes movement-related symptoms like tremors and slower movement. Until now, scientists didn't fully understand how the misfolded protein α-synuclein spreads from one brain cell to another.
A team led by Stephen Strittmatter at Yale School of Medicine studied this process in detail. They created thousands of groups of cells with different surface proteins and tested which ones allowed α-synuclein to enter. The researchers found that two specific proteins, mGluR4 and NPDC1, were responsible for carrying the misfolded protein into healthy brain cells.
The team then used mice as a model to test whether blocking these proteins could slow Parkinson's disease progression. They genetically engineered mice so that either mGluR4 or NPDC1 no longer functioned, then exposed them to α-synuclein. The results showed that the mice without functional mGluR4 or NPDC1 did not develop accumulations of α-synuclein in their brains and didn't show Parkinson's-like symptoms.
Why It Matters
Parkinson's disease is a significant public health challenge in India, with over 200,000 people diagnosed each year. Understanding how the disease spreads could lead to new treatments that improve the lives of millions of Indians living with this condition.
Key Facts
- About 1.1 million Americans live with Parkinson's disease, and nearly 90,000 new cases are diagnosed each year.
- The misfolded protein α-synuclein is the main cause of Parkinson's disease progression.
- mGluR4 and NPDC1 are two proteins that help carry α-synuclein into healthy brain cells.
- Blocking these proteins could slow or stop Parkinson's disease progression.
Key Terms
- α-synuclein
- A misfolded protein that causes Parkinson's disease
- mGluR4 and NPDC1
- Two proteins on the surface of brain cells that help carry α-synuclein into healthy cells
Implications
Parkinson's disease is a significant public health challenge in India, with over 200,000 people diagnosed each year. Understanding how the disease spreads could lead to new treatments that improve the lives of millions of Indians living with this condition.
Leave a comment